https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-11-01 / Zhejiang Da Xue Xue Bao Yi Xue Ban 2007 Nov;36(6):592-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-11-01 / Zhejiang Da Xue Xue Bao Yi Xue Ban 2007 Nov;36(6):592-72007-11-01 00:00:002019-02-15 08:46:53[Dendritic cells pulsed with glioma RNA induce immunity against intracranial gliomas]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-07-20 / Immunology 2007 Dec;122(4):615-22
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-07-20 / Immunology 2007 Dec;122(4):615-222007-07-20 00:00:002019-02-15 08:59:49Enhanced antitumour immunity by combined use of temozolomide and TAT-survivin pulsed dendritic cells in a murine glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-01 / Bull. Exp. Biol. Med. 2007 Apr;143(4):528-34
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-01 / Bull. Exp. Biol. Med. 2007 Apr;143(4):528-342007-04-01 00:00:002019-02-15 08:59:47Use of interferon-alpha-induced dendritic cells in the therapy of patients with malignant brain gliomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-01 / J. Neurosurg. 2007 Apr;106(4):638-45
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-01 / J. Neurosurg. 2007 Apr;106(4):638-452007-04-01 00:00:002019-02-15 08:59:50Antitumor effects of vaccination with dendritic cells transfected with modified receptor for hyaluronan-mediated motility mRNA in a mouse glioma model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-01 / Expert Opin Biol Ther 2007 Apr;7(4):439-48
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-01 / Expert Opin Biol Ther 2007 Apr;7(4):439-482007-04-01 00:00:002019-02-15 08:59:52Dendritic cell-based active specific immunotherapy for malignant glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-03-15 / J. Neurooncol. 2007 Sep;84(2):131-40
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-03-15 / J. Neurooncol. 2007 Sep;84(2):131-402007-03-15 00:00:002021-11-15 15:39:28Persistent IL-10 production is required for glioma growth suppressive activity by Th1-directed effector cells after stimulation with tumor lysate-loaded dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-15 / Clin. Cancer Res. 2007 Jan;13(2 Pt 1):566-575
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-15 / Clin. Cancer Res. 2007 Jan;13(2 Pt 1):566-5752007-01-15 00:00:002019-02-15 08:59:53Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-10 / J. Virol. 2007 Mar;81(6):2817-30
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-10 / J. Virol. 2007 Mar;81(6):2817-302007-01-10 00:00:002019-02-15 09:00:16p53-independent endoplasmic reticulum stress-mediated cytotoxicity of a Newcastle disease virus strain in tumor cell lines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-12-01 / Neurochirurgie 2006 Dec;52(6):555-70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-12-01 / Neurochirurgie 2006 Dec;52(6):555-702006-12-01 00:00:002019-02-15 08:59:55[Dendritic cells and gliomas: a hope in immunotherapy?]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-11-01 / Neurosurgery 2006 Nov;59(5):988-99; discussioin 999-1000
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-11-01 / Neurosurgery 2006 Nov;59(5):988-99; discussioin 999-10002006-11-01 00:00:002021-11-15 15:39:05Dendritic cell vaccination in patients with malignant gliomas: current status and future directions
